-
3144
-
2212
-
1470
-
1184
-
986
Characteristics of Voice Onset Time among Speakers of Jordanian Arabic with Parkinson’s Disease
DOI:
https://doi.org/10.30564/fls.v7i1.7374Abstract
Background: The voice onset time (VOT) is an acoustic measure to assess speech neuroregulatory mechanisms. However, the VOT was not measured in individuals of Jordanian Arabic with Parkinson's Disease (PD). Therefore, this research aimed to measure the VOT using a cross-sectional design. Sixteen individuals with PD and 16 healthy controls had their VOT assessed under two treatment conditions (Off and On-medication). The VOT was measured in several phonetic contexts. The results revealed a higher VOT effect among voiceless consonants for the PD in both experimental conditions than controls. Whereas no effects were observed among the voiced consonants between the two groups. In comparison, no differences were observed in the VOT between the voiceless and voiced consonants among the PD group in the Off-medication condition. The administration of the levodopa affected the VOT measure; a significant decrease in VOT among the voiceless and voiced consonants was observed between the Off and On-medication conditions. Additionally, no significant impacts on VOT were found among the PD individuals when comparing front and back consonants, rounded and unrounded vowels, high and low vowels, and among words versus a sentence. However, the VOT may vary according to the phonetic characteristics of speech and medication status among patients with PD. The VOT is still considered a sensitive acoustic measure to investigate speech production's neuroregulatory mechanisms and levodopa's effect among individuals with PD in Arabic. Notably, these acoustical markers only represent the first step in the objective biological screening of PD from speech signals.
Keywords:
Parkinson’s Disease; Voice Onset Time; Voiceless Consonants; Voiced Consonants; Off-Medication; On-MedicationReferences
[1] Dorsey, E.R., Constantinescu, R., Thompson, J.P., et al., 2007. Projected number of people with Parkinson's disease in the most populous nations, 2005 through 2030. Neurology. 68, 384–386. DOI: https://doi.org/10.1212/01.wnl.0000247740.47667.03
[2] Abbas, M.M., Xu, Z., Tan, C.S., 2017. Epidemiology of Parkinson's Disease-East Versus West. Movement Disorders Clinical Practice. 5, 14–28. DOI: https://doi.org/10.1002/mdc3.12568
[3] Fereshtehnejad, S.M., Vosoughi, K., Heydarpour, P., et al., 2019. Burden of neurodegenerative diseases in the Eastern Mediterranean Region, 1990–2016: findings from the Global Burden of Disease Study 2016. European Journal Neurology. 26(10), 1252–1265. DOI: https://doi.org/10.1111/ene.13972
[4] Alrefai, A., Habahbih, M., Alkhawajah, M., et al., 2009. Prevalence of Parkinson's disease in Northern Jordan. Clinical neurology and neurosurgery. 111(10), 812–815. DOI: https://doi.org/10.1016/j.clineuro.2009.08.010
[5] Safiri, S., Noori, M., Nejadghaderi, S.A., et al., 2023. The burden of Parkinson's disease in the Middle East and North Africa region, 1990–2019: results from the global burden of disease study 2019. BMC Public Health. 23, 107–119.
[6] Galvan, A., Devergnas, A., Wichmann, T., 2015. Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the Parkinsonian state. Frontiers in Neuroanatomy. 5, 9–15. DOI: https://doi.org/10.3389/fnana.2015.00005
[7] Truong, D.D., Bhidayasiri, R., Wolters, E., 2008. Management of non-motor symptoms in advanced Parkinson's disease. Journal of the Neurological Sciences. 266, 216–228. DOI: https://doi.org/10.1016/j.jns.2007.08.015
[8] Perrotta, G., 2020. Dysarthria: Definition, clinical contexts, neurobiological profiles, and clinical treatments. Archives of Community Medicine and Public Health. 6, 142–145. DOI: https://dx.doi.org/10.17352/2455-5479.000094
[9] Ho, A.K., Iansek, R., Marigliani, C., et al., 1999. Speech impairment in a large sample of patients with Parkinson's disease. Behavioural Neurology. 11, 131–137.
[10] Goberman, A.M., Coelho, C.A., Robb, M.P., 2005. Prosodic Characteristics of Parkinsonian Speech: The Effect of Levodopa-Based Medication. Journal of medical speech-language pathology. 13, 51–68.
[11] Bóna, J., 2023. Speech rate and fluency in young-onset Parkinson's disease: A longitudinal case study from early to post brain surgery stage. Clinical Linguistics & Phonetics. 37, 385–397. DOI: https://doi.org/10.1080/02699206.2022.2138784
[12] Kulikov, V., 2020. Laryngeal Contrast in Qatari Arabic: Effect of Speaking Rate on Voice Onset Time. Phonetica. 77, 163–185.
[13] Forrest, K., Weismer, G., Turner, G., 1989. Kinematic, acoustic, and perceptual analyses of connected speech produced by Parkinsonian and normal geriatric males. The Journal of the Acoustical Society of America. 85, 2608–2622. DOI: https://doi.org/10.1121/1.397755
[14] Bunton, K., Weismer, G., 2002. Segmental level analysis of laryngeal function in persons with motor speech disorders. Folia Phoniatrica et Logopaedica: official organ of the International Association of Logopedics and Phoniatrics (IALP). 54, 223–239. DOI: https://doi.org/10.1159/000065199
[15] Flint, A.J., Black, S.E., Campbell-Taylor, I., et al., 1992. Acoustic analysis in the differentiation of Parkinson's disease and major depression. International Journal of Psychological Research. 21, 383–399. DOI: https://doi.org/10.1007/BF01067922
[16] Karlsson, F., Unger, E., Wahlgren, S., et al., 2011. Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on diadochokinetic rate. Parkinson's Disease. 1–10. DOI: https://doi.org/10.4061/2011/605607
[17] Fischer, E., Goberman, A.M., 2010. Voice onset time in Parkinson's disease. Journal of Communication Disorders. 43, 21–34. DOI: https://doi.org/10.1016/j.jcomdis.2009.07.004
[18] Salat, D., Tolosa, E., 2013. Levodopa in the treatment of Parkinson's disease: current status and new developments. Journal of Parkinson's disease. 3(3), 255–269. DOI: https://doi.org/10.3233/JPD-130186
[19] Goberman, A.M., Coelho, C., 2002. Acoustic analysis of parkinsonian speech, I.: speech characteristics and L-Dopa therapy. Neurorehabilitation. 17, 237.
[20] Mračková, M., Mareček, R., Mekyska, J., et al., 2024. Levodopa may modulate specific speech impairment in Parkinson's disease: An fMRI study. Journal of Neural Transmission. 131, 181–187. DOI: https://doi.org/10.1007/s00702-023-02715-5
[21] Alghamdi, M., 2006. Voiceprint: Voice onset time as a model. Arab Journal for Security Studies and Training. 21, 89–118.
[22] Mitleb, F., 2009. Voice Onset of Jordanian Arabic Stops. The Journal of the Acoustical Society of America. 109, 2474. DOI: https://doi.org/10.1121/1.4744787
[23] Goetz, S., Tilley, C.G., Shaftman, B.C., et al., 2008. Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement disorders: official journal of the Movement Disorder Society. 23, 2129–2170.
[24] Winn, M., 2020. Manipulation of voice onset time in speech stimuli: A tutorial and flexible Praat script. Journal of the Acoustical Society of America. 147, 852–866. DOI: https://doi.org/10.1121/10.0000692
[25] Uludag, K., Wang, D.M., Goodman, C., et al., 2021. Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia. Asian Journal of Psychiatry. 66, 102877.
[26] Cho, T., Ladefoged, P., 1999. Variation and universals in VOT: evidence from 18 languages. Journal of Phonetics. 27, 207–229. DOI: https://doi.org/10.1006/jpho.1999.0094
[27] Chao, K.Y., Chen, L., 2008. A cross-linguistic study of voice onset time in stop consonant productions. International Journal of Computational Linguistics & Chinese Language Processing. 13, 215–232. Available from: https://aclanthology.org/O08-4005
[28] Lisker, L., Abramson, A.S., 1967. Some Effects of Context On Voice Onset Time in English Stops. Language and Speech. 10, 1–28. https://doi.org/10.1177/002383096701000101
[29] Van Dam, M., 2003. Voice Onset Time of American English Stops with Prosodic Correlates. The Journal of the Acoustical Society of America. 113, 2328. DOI: https://doi.org/10.1121/1.4780819
[30] Aljutaily, M., Alharbi, B., 2022. Voice Onset Time of Initial Stops in Najdi Arabic. World Journal of English Language. 12, 83–96. DOI: https://doi.org/10.5430/wjel.v12n6p83
[31] Kent, R.D., Read, C., 2002. The Acoustic Analysis of Speech, 2nd ed. Thomson Learning: Singapore.
[32] Bang, Y.I., Min, K., Sohn, Y.H., et al., 2013. Acoustic characteristics of vowel sounds in patients with Parkinson's disease. Neuro Rehabilitation. 32, 649–654. DOI: https://doi.org/10.3233/NRE-130887
[33] Espay, A.J., Pagan, F.L., Walter, B.L., et al., 2017. Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy. Neurology. Clinical practice. 7(1), 86–93. DOI: https://doi.org/10.1212/CPJ.0000000000000316
Downloads
How to Cite
Issue
Article Type
License
Copyright © 2025 Firas S. Alfwaress, Muhammad A. Badarneh, Rahaf A. Mousa
This is an open access article under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) License.